Tobramycin Inhalation Powder Is Effective and Safe in the Treatment of Chronic Pulmonary Pseudomonas aeruginosa (Pa) Infection in Patients with Cystic Fibrosis

被引：0
|
作者：
Konstan, M. W. [1 ]
Geller, D. E. [2 ]
Brockhaus, F. [3 ]
Zhang, J. [3 ]
Angyalosi, G. [3 ]
机构：
[1] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA
[2] Nemours Childrens Clin, Orlando, FL USA
[3] Novartis, Basel, Switzerland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1186
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
    Srilekha Panguluri
    Praveen Gunda
    Laurie Debonnett
    Kamal Hamed
    [J]. Clinical Drug Investigation, 2017, 37 : 795 - 805
  • [2] Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
    Panguluri, Srilekha
    Gunda, Praveen
    Debonnett, Laurie
    Hamed, Kamal
    [J]. CLINICAL DRUG INVESTIGATION, 2017, 37 (08) : 795 - 805
  • [3] Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
    Kate McKeage
    [J]. Drugs, 2013, 73 : 1815 - 1827
  • [4] Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
    McKeage, Kate
    [J]. DRUGS, 2013, 73 (16) : 1815 - 1827
  • [5] Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence
    Hamed, Kamal
    Debonnett, Laurie
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (05) : 193 - 209
  • [6] Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study
    Blasi, Francesco
    Carnovale, Vincenzo
    Cimino, Giuseppe
    Lucidi, Vincenzina
    Salvatore, Donatello
    Messore, Barbara
    Bartezaghi, Marta
    Muscianisi, Elisa
    Porpiglia, Pasquale Alberto
    [J]. RESPIRATORY MEDICINE, 2018, 138 : 88 - 94
  • [7] Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis
    Lam, John
    Vaughan, Steven
    Parkins, Michael D.
    [J]. CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2013, 7 : 61 - 77
  • [8] Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis
    Somayaji, Ranjani
    Parkins, Michael D.
    [J]. THERAPEUTIC DELIVERY, 2015, 6 (02) : 121 - 137
  • [9] Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin
    Akkerman-Nijland, Anne M.
    Yousofi, Mina
    Rottier, Bart L.
    Van der Vaart, Hester
    Burgerhof, Johannes G. M.
    Frijlink, Henderik W.
    Touw, Daan J.
    Koppelman, Gerard H.
    Akkerman, Onno W.
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [10] BUDGET IMPACT ANALYSIS OF THE USE OF TOBRAMYCIN INHALATION POWDER (TIP) FOR THE TREATMENT OF CHRONIC PSEUDOMONAS AERUGINOSA (PA) INFECTION IN PATIENTS WITH CYSTIC FIBROSIS AGED ≥ 6 YEARS IN MEXICO
    Lemus, A.
    Rosas, J.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A72 - A72
12345